ASTH APOLLO MEDICAL HLDGS INC

Ownership history in CITADEL ADVISORS LLC  ·  56 quarters on record

This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in APOLLO MEDICAL HLDGS INC (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q3)
Avg. % of fund
0.0%
First filed
2018 Q3
Last filed
2025 Q4
Quarters held
56
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 31,504 +13,204 +72.2% 0.00% $782K $24.81
2025 Q4 REDUCED 18,300 -34,218 -65.2% 0.00% $454K $24.81
2025 Q3 ADDED 52,518 +31,318 +147.7% 0.00% $1.5M $28.35
2025 Q3 REDUCED 21,200 -369,800 -94.6% 0.00% $601K $28.35
2025 Q3 ADDED 391,000 +207,110 +112.6% 0.00% $11.1M $28.35
2025 Q2 ADDED 183,890 +152,090 +478.3% 0.00% $4.6M $24.88
2025 Q2 ADDED 31,800 +20,300 +176.5% 0.00% $791K $24.88
2025 Q2 REDUCED 11,500 -268,799 -95.9% 0.00% $286K $24.88
2025 Q1 ADDED 280,299 +179,199 +177.2% 0.00% $8.7M $31.01
2025 Q1 ADDED 101,100 +92,200 +1036.0% 0.00% $3.1M $31.01
46 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ASTH price (monthly, adj. close)
← Back to CITADEL ADVISORS LLC Holdings